Free Trial

Connor Clark & Lunn Investment Management Ltd. Raises Stake in Nature's Sunshine Products, Inc. $NATR

Nature's Sunshine Products logo with Medical background

Key Points

  • Connor Clark & Lunn Investment Management Ltd. has increased its stake in Nature's Sunshine Products by 80.1%, owning approximately 0.21% of the company, valued at $484,000.
  • Nature's Sunshine Products recently reported a quarterly earnings per share of $0.35, exceeding the consensus estimate of $0.16, with revenues of $114.75 million.
  • Insider transactions included notable share sales from executives, with a total of 2,869,603 shares sold worth approximately $32.96 million over the last three months.
  • Looking to export and analyze Nature's Sunshine Products data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 80.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,602 shares of the company's stock after purchasing an additional 17,168 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.21% of Nature's Sunshine Products worth $484,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Janney Montgomery Scott LLC acquired a new stake in Nature's Sunshine Products during the first quarter worth about $340,000. Millennium Management LLC acquired a new stake in shares of Nature's Sunshine Products during the fourth quarter valued at about $1,135,000. GAMMA Investing LLC increased its position in shares of Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after acquiring an additional 2,132 shares during the last quarter. Northern Trust Corp increased its position in shares of Nature's Sunshine Products by 2.7% during the fourth quarter. Northern Trust Corp now owns 119,005 shares of the company's stock valued at $1,745,000 after acquiring an additional 3,174 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Nature's Sunshine Products by 16.8% during the fourth quarter. Ameriprise Financial Inc. now owns 51,182 shares of the company's stock valued at $750,000 after acquiring an additional 7,348 shares during the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature's Sunshine Products Stock Down 0.6%

Nature's Sunshine Products stock traded down $0.1070 during trading on Friday, reaching $16.5330. The stock had a trading volume of 85,272 shares, compared to its average volume of 64,180. Nature's Sunshine Products, Inc. has a 52-week low of $11.01 and a 52-week high of $18.06. The business has a 50 day moving average price of $15.32 and a 200 day moving average price of $14.11. The stock has a market cap of $291.58 million, a PE ratio of 22.34 and a beta of 1.14.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.19. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The company had revenue of $114.75 million during the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products has set its FY 2025 guidance at EPS.

Analyst Ratings Changes

A number of equities research analysts have weighed in on NATR shares. DA Davidson reiterated a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a research report on Tuesday, June 3rd. Canaccord Genuity Group lifted their price target on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $19.67.

Get Our Latest Stock Report on Nature's Sunshine Products

Insider Buying and Selling at Nature's Sunshine Products

In other Nature's Sunshine Products news, CAO Jonathan David Lanoy sold 5,000 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $16.51, for a total value of $82,550.00. Following the transaction, the chief accounting officer directly owned 50,051 shares of the company's stock, valued at approximately $826,342.01. The trade was a 9.08% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Nathan G. Brower sold 9,996 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total transaction of $165,333.84. Following the completion of the transaction, the executive vice president directly owned 48,277 shares in the company, valued at $798,501.58. This represents a 17.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 2,869,603 shares of company stock valued at $32,961,680. 4.70% of the stock is owned by company insiders.

About Nature's Sunshine Products

(Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Stories

Institutional Ownership by Quarter for Nature's Sunshine Products (NASDAQ:NATR)

Should You Invest $1,000 in Nature's Sunshine Products Right Now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines